Seminarios web
228 articles
Testing the Effect of a Malaria Drug on Standard Treatment
A clinical trial tests whether a malaria drug can make standard chemotherapy for advanced pancreatic cancer more effective.
Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation
A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.
Quality of Life and Following My Dream
Lee Wonnacott valued his quality of life when he chose treatment for IPMN. Now he rides his motorcycle around the country to honor veterans.
Newly Diagnosed
What to Do If You Are Newly Diagnosed with Pancreatic Cancer You or someone you love has been diagnosed with pancreatic cancer. Now what? First, take a breath and know that you are not alone in this overwhelming moment. Let’s Win has the most up-to-date information, research, and resources to help you make informed decisions […]
Willa Shalit
Willa Shalit—artist, author, social entrepreneur and philanthropist—uses art and media to achieve social change. Willa is Founding Partner in the consulting firm Road to Market where she leads cause-related and corporate marketing and communications projects. She brought women’s economic opportunity into post-conflict zones and communities devastated by natural disasters, working with Palestinian and Israeli women, […]
Cindy Price Gavin
Cindy Price Gavin brings to Let’s Win over 30 years of professional experience in the nonprofit and financial services fields. Prior to joining Let’s Win, Cindy was the founding Executive Director of Michael’s Mission, a 501(c)(3) organization focused on improving the quality of life and treatment options for patients struggling with colorectal cancer. In her […]
Using a Colon Cancer Drug to Treat Advanced Pancreatic Cancer
A clinical trial tests the effectiveness of an approved colon cancer drug against advanced pancreatic neuroendocrine cancer.
Exploring the Effectiveness of an Experimental Class of Drug
Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?
A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery
Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.
Slowing the Growth of Pancreatic Tumors Before Surgery
A chemoradiation clinical trial tests standard chemotherapy plus an anti-malaria drug and compares two types of radiation treatments, to slow tumor growth.
High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors
A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.
A Novel Combination to Slow Pancreas Tumors that Cannot Be Surgically Removed
Can a combination of standard drugs, a PARP inhibitor, and intensity modulated radiation therapy to slow pancreatic tumor growth?
A New Drug Combination to Control Advanced Pancreatic Cancer
A clinical trial for pancreatic cancer patients with the BRCA mutation tests the effectiveness of standard treatment plus a PARP inhibitor.
Using a Vitamin to Make Low-Dose Chemotherapy More Effective
A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.
Immunotherapy to Help Shrink Pancreatic Tumors for Surgery
Researchers are looking at adding checkpoint drugs–a type of immunotherapy–to standard chemoradiation to shrink pancreatic cancer for surgery.